Fractal Analytics Ltd held its Q2 FY27 earnings call on November 03, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.
First $100M Quarter, Entirely Organic, Profitability Outpacing Revenue
Revenue of Rs.957 crore crossed $100 million for the first time — up 20% YoY and 5% QoQ (10% YoY / 4% QoQ in CC), entirely organic; H1 FY 2026-2027 revenue of Rs.1,869 crore, up 20% YoY (10% CC).
Adjusted EBITDA grew 30% YoY — margin of 16.2% (+123 bps YoY), outpacing 20% revenue growth; SG&A leveraged from 27% to 23.6% of revenue despite 5% absolute growth.
Net income of Rs.79 crore, up 139% YoY — margin 8.3% (+413 bps); diluted EPS of 4.48 (+132% YoY); ex-associate (Cure.ai) net income of Rs.102 crore (10.7% of revenue, EPS 5.76).
Gross margin of 44%, down 225 bps YoY — AI engineering talent investment -279 bps, merit increases -216 bps, weaker rupee +270 bps; drag sits in delivery expense (FDE build-out), not research spend.
R&D investment up 13% YoY to Rs.60 crore — 6.3% of revenue (Rs.40 crore expensed, remainder capitalized), mostly directed at Cogentic and Asper.
Cash of Rs.1,728 crore (incl. mutual funds and FDs) as of 30 September 2026, including Rs.608 crore of remaining IPO proceeds; trailing 12-month operating cash flow of Rs.407 crore, up 11% YoY; DSO rose 5 days to 76 days, expected to return to historical range by end of FY 2026-2027.
HLS Leads at +79%; TMT Turns After Five Quarters of Decline; CPG Muted
Healthcare & life sciences grew +79% YoY — the growth leader; CEO Srikanth Velamakanni attributed vertical divergence to industry dynamics (adoption, complexity, macro) rather than Fractal's execution, describing healthcare as an extremely complex industry that will benefit significantly from AI.
BFSI +30% and "others" (energy/travel/industrial) +47% YoY — HLS and BFSI delivered strong growth for a third consecutive quarter.
CPG & retail, the largest vertical, grew +11% YoY — and declined sequentially; management cited Q1 FY 2026-2027 budgetary "surge" seasonality, high inflation, and consolidation among large CPG players, which delayed some contract signings; management did not confirm any specific project discontinuation.
TMT grew +6% sequentially — turning positive after five consecutive quarters of sequential decline; management expects the recovery to continue through Q3 and Q4 FY 2026-2027, noting most of Fractal's TMT work is with the commercial organizations of TMT clients, which it described as "AI starved".
Geographic growth (YoY): Americas +22%, Europe +20%, APAC +7% — in Q2 FY 2026-2027.
Client metrics strengthened — NPS of 76; net revenue retention of 115% (vs 112% in Q2 FY 2025-2026) plus 5 points from new clients; 58 clients above $1 million in annual revenue (20 above $5 million); top-10 concentration fell from 53.2% to 51.7% of revenue.
Agentic AI Platform Gaining Traction; FDE Build-Out Sets Up the Inflection
Cogentic (agentic AI platform) is "doing really well" — all revenue license-based; management claims it beats existing alternatives, including clients building in-house, in competitive situations; depth applications include Cogentic Invoice-to-Cash and Cogentic CX (voice API at very competitive rates).
Management aspiration: Cogentic to become the default way Fractal delivers all services — as that becomes the norm, it expects meaningful improvement in overall economics and views Cogentic as a very significant growth lever over the next few quarters and years.
Frontier labs are routing inbound leads to Fractal — one (cited as Cogentic CX) brings Fractal in where its voice AI solution cannot cover client requirements; a second routes leads for product activation and enterprise "harness" build-outs; Fractal was also named retail CPG partner of the year with Microsoft, and its AWS work is expanding.
Revenue mix by AI theme (management's rough framing, no precise breakup) — ~60% AI transformation, ~35% enterprise knowledge/context layer, ~5% redesigning work itself; by problem solved: ~40% client revenue growth, ~30% operational effectiveness, ~10-15% R&D/innovation, ~10-15% day-to-day performance management, under 5% sustainability/ESG.
Management cited a 48% quarter-over-quarter reduction in the cost of intelligence from foundation models — implying a 93% decline over a year — and expects a significant scale-up of enterprise AI in FY 2027-2028, with revenue-per-employee improving meaningfully in that fiscal.
Revenue per billable FDE marginally up in rupee terms, slightly lower in dollars — attributed to deliberate capacity build-ahead (hiring, acqui-hire and deep AI-engineering M&A), not pricing.
Product Run-Rate +39% YoY; Qure.ai Rebuilding After USAID Shock
Products revenue of Rs.38 crore in Q2 FY 2026-2027 (4% of total) — portfolio run-rate above Rs.150 crore/year, up 39% YoY; products RPO over Rs.200 crore as of Q2 FY 2026-2027.
Fractal Alpha revenue of Rs.34 crore, up 40% YoY and 41% QoQ (32% YoY CC); adjusted segment loss of Rs.10 crore with 54% gross margin; Analytics Vidhya B2B build-out weighed on margins, expected to normalize by end of FY 2026-2027.
Product revenue target of roughly $100 million run-rate in about 12 quarters from the call (≈ FY 2029-2030) — tied to a roadmap of products/licensing reaching 20% of revenues (period unspecified); management said the ramp is non-linear by design, with product revenue expected to rise sequentially from ~4% to 5%, 6%, 7% over the next few quarters beginning Q3 FY 2026-2027.
PricingOne transaction closed 2 November 2026 — gives Asper a foothold in Europe; a pricing-focused acqui-hire was recently completed.
Qure.ai (31.5% associate holding, no further investment planned) revenue of Rs.28 crore, up 82% YoY — but Fractal's share of loss was Rs.23 crore in Q2 FY 2026-2027; the Trump administration's DOGE program completely shut down USAID in FY 2026-2027, causing Qure.ai revenue to decline precipitously.
Qure.ai rebuilding via stronger US and Europe businesses — strong pipeline and backlog for the remainder of FY 2026-2027; management views the stake as "hugely positive" to Fractal's overall value, though the market effectively assigns potentially negative valuation to the stake because Qure.ai losses drag down Fractal's profitability-focused valuation.
Large-Deals Team in Build-Out; M&A Pipeline "Very Decent"
6 clients each generating more than $20 million — up from 4 in Q2 FY 2025-2026; new client additions running at about 1 every 10 days, with win rates moving in the right direction.
Dedicated large-deals team being set up — to pursue larger transactions involving enterprise knowledge/context layers; deal sizes are rising for Fractal, contrary to the broader tech-services trend; large deals are not a meaningful part of current revenue growth but management expects them to become a very meaningful part of future revenue growth.
Partnership-led revenues expected to become more meaningful — management made strengthening the partnership muscle a priority in FY 2026-2027 after under-capitalizing on the opportunity in FY 2025-2026.
M&A: "quite active" with a "very decent pipeline" and a board keen to explore — targets include deep AI engineering talent with strong local presence across geographies and industry-specific deep expertise; deals must increase Fractal's "right to win" and deliver a multiplicative, not merely additive, impact on future growth potential.
Capital allocation framework: maximize revenue growth while taking Fractal.ai EBITDA as close to 22% (period unspecified) — CEO Srikanth Velamakanni described this as an implicit/explicit agreement maintained with investors throughout the company's history.
Margin Recovery From Q3; Alpha Break-Even in FY 2027-2028; No Numeric Guidance
Gross margin expected to recover as early as Q3 FY 2026-2027 and further in Q4 FY 2026-2027 — management expects a "quite significant" recovery in Q3-Q4 FY 2026-2027, aided by seasonality (gross margins typically lowest in Q1) and FY 2026-2027 wage hikes shifted to June, which concentrated the impact in Q2.
Profitability improvement expected across Q3-Q4 FY 2026-2027 and all of FY 2027-2028 — with a "decent improvement" by Q4 FY 2026-2027 on both sequential and YoY bases; management reiterated the IPO commitment to continuously improve profitability, calling healthy profitability levels "within arm's length".
Fractal Alpha approaching break-even as early as end of FY 2026-2027 — and breaking even certainly in FY 2027-2028, with robust sequential growth at higher margins expected over Q3-Q4 FY 2026-2027.
CPG expected to grow sequentially in Q3 and Q4 FY 2026-2027 — with YoY growth, currently "not as spectacular as we would like", expected to be much better by FY 2027-2028.
G&A discipline maintained — ran at ~12% of revenue in Q1 and Q2 FY 2026-2027; management reiterated a model of growing G&A at roughly half the rate of revenue growth (period unspecified), with SG&A leverage playing out across FY 2026-2027 and FY 2027-2028.
Management said enterprise AI adoption floodgates have not opened yet — Fractal stands ready to capitalize when they do; no forward numeric guidance was provided on the call.
Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings